Gültekin ADANAS AYDIN, Gülten ÖZGEN, Özcan EREL, Salim NEŞELİOĞLU

Serum ischemia modified albumin and dynamic thiol/disulfide homeostasis in early- and late-onset preeclampsia

Aim: In the present study, we aimed to evaluate serum IMA, IMA/albumin ratio, and DTDH levels in patients with early- and late-onset PE compared to healthy controls.Impaired homeostasis between oxidant and antioxidant mechanisms, inflammatory processes, and endothelial dysfunction play a key role in the pathogenesis of preeclampsia (PE). Serum ischemia modified albumin (IMA) and dynamic thiol/disulfide homeostasis (DTDH) levels are elevated in the presence of inflammation, oxidative stress, and endothelial dysfunction. Material and Methods: A total of 24 patients with early-onset PE and 62 patients with late-onset PE were included.The control group consisted of 46 healthy controls with similar gestational weeks. Serum samples were collected and IMA, albumin, and native, total, and disulfide thiol levels analyzed. Corrected IMA/albumin ratios were also calculated.Results: Disulfide levels, disulfide/native and disulfide/total thiol levels were higher in patients with early-onset PE compared to late-onset patients(p=0.008, p=0.022, and p=0.021, respectively). However, there was no significant difference between the late-onset PE patients and late-onset PE controls. Although there was no significant difference in the IMA levels between the patient and control groups, the IMA/albumin ratio was higher in the early-onset and late-onset PE patients, compared to the control group. However, there was no significant difference between the early-onset and late-onset PE patients.Conclusion: Our study results showed increased disulfide levels, disulfide/native thiol, disulfide/total thiol and IMA/albumin ratio in the early-onset PE patients, indicating increased oxidative stress in the pathogenesis of PE. In the late-onset PE patients, there was an increase only in the IMA/albumin ratio. However, further large-scale, prospective studies are needed to confirm the diagnostic value of these markers in the clinical practice.

PDF

___

1. SaleemS, McClureEM, Goudar SS, et al. The Global Network Maternal Newborn Health Registry Study Investigators.A prospective study of maternal, fetal and neonatal deaths in lowand middle-income countries.Bull World Health Organ 2014;92:605-12.
2. Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia.Obstet Gynecol 2014;124:771.
3. Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006;45:189- 200.
4. Jones DP, Liang Y. Measuring the poise of thiol/ disulfide couples in vivo. Free RadicBiol Med 2009;47:1329-38.
5. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. ClinBiochem 2014;47: 326-32.
6. TurellL,RadiR, Alvarez B.The thiol pool in human plasma: the central contribution of albumin to redox processes. Free RadicBiol Med 2013;65:244-53.
7. Taverna M, Marie AL, Mira JP, et al. Specific antioxidant properties of human serumalbumin. Ann Intensive Care 2013;3:4.
8. Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co (2+) and Ni(2+) binding amino acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42-7.
9. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt albumin binding and itspotential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5.
10. Madazli R, Yuksel MA, Imamoglu M, et al. Comparison of clinicalandperinataloutcomes in early- andlateonsetpreeclampsia. Arch Gynecol Obstet 2014;290:53- 7.
11. Seshadri Reddy V, Duggina P, Vedhantam M, et al. Maternal serum and fetal cord-blood ischemiamodified albumin concentrations in normal pregnancy and preeclampsia: a systematic review and metaanalysis. J Matern Fetal Neonatal Med 2017;29:1-12.
12. Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310.
13. Lippi G, Montagnana M, Salvagno GL, et al. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. ClinChem Lab Med. 2007;45:261-2.
14. Gafsou B, Lefèvre G, Hennache B, et al. Maternal serum ischemia-modified albumin:a biomarker to distinguish between normal pregnancy and preeclampsia? HypertensPregnancy2010;29:101-11.
15. Vyakaranam S, Bhongir AV, Patlolla D, et al. Maternal serum ischemia modifiedalbumin as a marker for hypertensive disorders of pregnancy: a pilot study. Int J Reprod Contracept Obstet Gynecol2015;4:611-6.
16. Dogan K, Guraslan H, Cankaya A, et al. Ischemia- Modified Albumin (IMA): A Novel Marker for Preeclampsia Independent of Uterine Artery Notching Identified by Doppler Ultrasound. Hypertens Pregnancy 2015;34:516-24.
17. D'souza JM, Pai VR, Harish S, Shriyan C, D'souza N. IMA and IMAR in serum andsaliva of preeclampsia--a preliminary study. Hypertens Pregnancy 2014;33:440- 8.
18. Hakligor A, Kosem A, Senes M, et al. Effect of albumin concentration and serummatrix on ischemia-modified albumin. Clin Biochem2010;43:345-814. 27.Bahinipati J, Mohapatra PC. Ischemia Modified Albumin as a Marker of Oxidative Stress in Normal Pregnancy. J ClinDiagn Res 2016;10:15-7.
19. Bahinipati J, Mohapatra PC. Ischemia Modified Albumin as a Marker of Oxidative Stress in Normal Pregnancy. J ClinDiagn Res 2016;10:15-7.
20. Bahinipati J, Mohapatra PC, Pradhan T. Role of maternal serum ischemia modifiedalbumin as a biochemical marker in preeclampsia. Biomedical Research 2014;25:153-6.
21. Seshadri Reddy V, Munikumar M, Duggina P, et al. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia.JMatern Fetal Neonatal Med 2019;32:2173-81.
22. Ozler S, Erel O, Oztas E, et al. Serum Thiol/Disulphide Homeostasis in Preeclampsia.Hypertens Pregnancy 2015;34:474-85.
23. Korkmaz V, Kurdoglu Z, Alisik M, et al. Impairment of thiol disulphide homeostasis in preeclampsia. JMatern Fetal Neonatal Med 2016;29:3848-53.
24. Yuvaci HU, Akdemir N, Bostanci MS, et al. Evaluation of the level of thiol-disulphide homeostasis in preeclampsia. Pregnancy Hypertens 2016;6:394-9.